Olivia Brayer
Stock Analyst at Cantor Fitzgerald
(1.24)
Main Sectors:
Top Industries:
| Name | Action | PT | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
VRNA Verona Pharma | Maintains: Overweight | 90 100 | 105.25 | -4.99% | 1 | Jun 11, 2025 | |
UTHR United Therapeutics | Initiates Coverage On: Overweight | 405 | 300.44 | 34.8% | 1 | Jun 2, 2025 | |
VNDA Vanda Pharmaceutical... | Assumes: Overweight | 13 | 4.18 | 211% | 1 | May 14, 2025 | |
BMRN Biomarin Pharmaceuti... | Reiterates: Overweight | 90 90 | 56.8 | 58.45% | 15 | Feb 20, 2025 | |
VRTX Vertex Pharmaceutica... | Reiterates: Overweight | 480 480 | 374.47 | 28.18% | 22 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 50 55 | 45.94 | 19.72% | 9 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 80 80 | 120.57 | -33.65% | 10 | Dec 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | n/a | n/a | n/a | 1 | Nov 14, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 1015 1015 | 546.18 | 85.84% | 8 | Oct 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 405 405 | 285.1 | 42.06% | 2 | Oct 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Neutral | 220 220 | 434.89 | -49.41% | 23 | Oct 11, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 10 10 | 11.42 | -12.43% | 5 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Overweight | 7 7 | 3.42 | 90.06% | 4 | May 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 72 | 55.44 | 29.87% | 1 | Apr 13, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Neutral | 56 21 | 3.18 | 560.38% | 2 | Feb 23, 2023 |